Skip to main content
Bryan Hambley, MD, Hematology, Cincinnati, OH, University of Cincinnati Medical Center

BryanChristopherHambleyMD

Hematology • Cincinnati, OH

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Hambley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hambley's full profile

Already have an account?

Summary

  • I am a hematologist in Cincinnati focusing on blood cancers and bone marrow/stem cell transplantation. I attended medical school at Tulane, followed by residency in Cleveland at University Hospitals, where I also completed a critical care fellowship. I trained in hematology, focusing on leukemia and stem cell transplantation at Johns Hopkins. After completing our training, my wife and I moved to Cincinnati to begin our careers. I am a passionate believer in universal access to high-quality and affordable healthcare and the dignity of every human being.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2017 - 2019
  • University Hospitals Cleveland Medical Center
    University Hospitals Cleveland Medical CenterCritical Care Medicine, 2016 - 2017
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2012 - 2015
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 2012

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2012 - 2024
  • MD State Medical License
    MD State Medical License 2017 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
    Bryan Hambley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with Cancer
    Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with CancerNovember 20th, 2021
  • Multiple Myeloma: Hope That Colin Powell's Death Will Encourage Vaccination in Cincinnati
    Multiple Myeloma: Hope That Colin Powell's Death Will Encourage Vaccination in CincinnatiOctober 21st, 2021
  • Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research Shows
    Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research ShowsDecember 6th, 2019

Hospital Affiliations

Dr. Bryan Hambley, Dr. Bryan Hambley, MD, Dr. B Hambley, Dr. Bryan Christopher Hambley